These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 14602374

  • 21. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
    Fung CP, Jang TN, Liu CY, Lau YJ, Liu YC, Chuang YC, Lee N.
    J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
    [Abstract] [Full Text] [Related]

  • 22. [Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].
    Tian HL, Shi W, Zhou HF, Yuan L, Yao KH, Rexiati D, Xu AM.
    Zhonghua Er Ke Za Zhi; 2018 Apr 02; 56(4):279-283. PubMed ID: 29614568
    [Abstract] [Full Text] [Related]

  • 23. BRO beta-lactamase alleles, antibiotic resistance and a test of the BRO-1 selective replacement hypothesis in Moraxella catarrhalis.
    Levy F, Walker ES.
    J Antimicrob Chemother; 2004 Feb 02; 53(2):371-4. PubMed ID: 14729761
    [Abstract] [Full Text] [Related]

  • 24. [Susceptibility of Branhamella catarrhalis to antibiotics].
    Leszczyńska K, Jakoniuk P, Sacha PT, Zalewska M, Wieczorek P.
    Med Dosw Mikrobiol; 2004 Feb 02; 56(3):231-7. PubMed ID: 15773499
    [Abstract] [Full Text] [Related]

  • 25. Long-term trends in susceptibility of Moraxella catarrhalis: a population analysis.
    Walker ES, Neal CL, Laffan E, Kalbfleisch JH, Berk SL, Levy F.
    J Antimicrob Chemother; 2000 Feb 02; 45(2):175-82. PubMed ID: 10660499
    [Abstract] [Full Text] [Related]

  • 26. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
    Bootsma HJ, van Dijk H, Vauterin P, Verhoef J, Mooi FR.
    Mol Microbiol; 2000 Apr 02; 36(1):93-104. PubMed ID: 10760166
    [Abstract] [Full Text] [Related]

  • 27. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
    Hoban D, Felmingham D.
    J Antimicrob Chemother; 2002 Sep 02; 50 Suppl S1():49-59. PubMed ID: 12239228
    [Abstract] [Full Text] [Related]

  • 28. Apparent plateau in beta-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiative.
    Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Thornsberry C, Sahm DF.
    Int J Antimicrob Agents; 2002 Feb 02; 19(2):119-23. PubMed ID: 11850164
    [Abstract] [Full Text] [Related]

  • 29. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
    Richter SS, Winokur PL, Brueggemann AB, Huynh HK, Rhomberg PR, Wingert EM, Doern GV.
    Antimicrob Agents Chemother; 2000 Feb 02; 44(2):444-6. PubMed ID: 10639381
    [Abstract] [Full Text] [Related]

  • 30. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993.
    Nissinen A, Grönroos P, Huovinen P, Herva E, Katila ML, Klaukka T, Kontiainen S, Liimatainen O, Oinonen S, Mäkelä PH.
    Clin Infect Dis; 1995 Nov 02; 21(5):1193-6. PubMed ID: 8589142
    [Abstract] [Full Text] [Related]

  • 31. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A, Janicka G, Krawiecka D, Kochanowska J.
    Med Sci Monit; 2000 Nov 02; 6(2):300-4. PubMed ID: 11208326
    [Abstract] [Full Text] [Related]

  • 32. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
    Bootsma HJ, van Dijk H, Verhoef J, Fleer A, Mooi FR.
    Antimicrob Agents Chemother; 1996 Apr 02; 40(4):966-72. PubMed ID: 8849261
    [Abstract] [Full Text] [Related]

  • 33. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis.
    du Plessis M.
    Diagn Microbiol Infect Dis; 2001 Jan 02; 39(1):65-7. PubMed ID: 11173194
    [Abstract] [Full Text] [Related]

  • 34. Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
    Schmitz FJ, Beeck A, Perdikouli M, Boos M, Mayer S, Scheuring S, Köhrer K, Verhoef J, Fluit AC.
    J Clin Microbiol; 2002 Apr 02; 40(4):1546-8. PubMed ID: 11923393
    [Abstract] [Full Text] [Related]

  • 35. In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
    Schmitz FJ, Boos M, Mayer S, Verhoef J, Milatovic D, Fluit AC.
    J Antimicrob Chemother; 2002 Jan 02; 49(1):220-3. PubMed ID: 11751796
    [No Abstract] [Full Text] [Related]

  • 36. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S, Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Nov 02; 53(3):225-31. PubMed ID: 16257168
    [Abstract] [Full Text] [Related]

  • 37. In vitro investigation of the indirect pathogenicity of beta-lactamase-producing microorganisms in the nasopharyngeal microflora.
    Kaieda S, Yano H, Okitsu N, Hosaka Y, Okamoto R, Inoue M, Takahashi H.
    Int J Pediatr Otorhinolaryngol; 2005 Apr 02; 69(4):479-85. PubMed ID: 15763284
    [Abstract] [Full Text] [Related]

  • 38. Antibiotic susceptibilities among recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis from fifteen countries.
    Bandak SI, Turnak MR, Allen BS, Bolzon LD, Preston DA, Bouchillon SK, Hoban DJ.
    Eur J Clin Microbiol Infect Dis; 2001 Jan 02; 20(1):55-60. PubMed ID: 11245326
    [Abstract] [Full Text] [Related]

  • 39. Moraxella catarrhalis: A Cause of Concern with Emerging Resistance and Presence of BRO Beta-Lactamase Gene-Report from a Tertiary Care Hospital in South India.
    Raveendran S, Kumar G, Sivanandan RN, Dias M.
    Int J Microbiol; 2020 Jan 02; 2020():7316257. PubMed ID: 32089697
    [Abstract] [Full Text] [Related]

  • 40. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa.
    Powell M, McVey D, Kassim MH, Chen HY, Williams JD.
    J Antimicrob Chemother; 1991 Aug 02; 28(2):249-59. PubMed ID: 1778856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.